Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab
Heine, R J S D, Thielen, F W, Mathijssen, R H J, van Leeuwen, R W F, Franken, M G, Uyl-de Groot, C A
Published in PloS one (01.02.2024)
Published in PloS one (01.02.2024)
Get full text
Journal Article
Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents
Gaultney, J. G., Franken, M. G., Tan, S. S., Redekop, W. K., Huijgens, P. C., Sonneveld, P., Uyl-de Groot, C. A.
Published in Journal of clinical pharmacy and therapeutics (01.02.2013)
Published in Journal of clinical pharmacy and therapeutics (01.02.2013)
Get full text
Journal Article
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
De Groot, S, Blommestein, H M, Redekop, W K, Sleijfer, S, Kiemeney, L A L M, Oosterwijk, E, Uyl-de Groot, C A
Published in PloS one (22.05.2017)
Published in PloS one (22.05.2017)
Get full text
Journal Article
Developing a decision tool to identify patients with personality disorders in need of highly specialized care
Goorden, M, Willemsen, E M C, Bouwmans-Frijters, C A M, Busschbach, J J V, Noomx, M J, van der Feltz-Cornelis, C M, Uyl-de Groot, C A, Hakkaart-van Roijen, L
Published in BMC psychiatry (31.08.2017)
Published in BMC psychiatry (31.08.2017)
Get full text
Journal Article
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck
van der Linden, N., van Gils, C. W. M., Pescott, C. P., Buter, J., Vergeer, M. R., Groot, C. A. Uyl-de
Published in European archives of oto-rhino-laryngology (01.08.2015)
Published in European archives of oto-rhino-laryngology (01.08.2015)
Get full text
Journal Article
Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial
van Ommen-Nijhof, A, Konings, I R, van Zeijl, C J J, Uyl-de Groot, C A, van der Noort, V, Jager, A, Sonke, G S
Published in BMC cancer (20.11.2018)
Published in BMC cancer (20.11.2018)
Get full text
Journal Article
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
Vellenga, E., Van Agthoven, M., Croockewit, A. J., Verdonck, L. F., Wijermans, P. J., Van Oers, M. H. J., Volkers, C. P., Van Imhoff, G. W., Kingma, T., Uyl‐de Groot, C. A., Fibbe, W. E.
Published in British journal of haematology (01.08.2001)
Published in British journal of haematology (01.08.2001)
Get full text
Journal Article
Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
Uyl-de Groot, C.A., Vermorken, J.B., Hanna, M.G., Verboom, P., Groot, M.T., Bonsel, G.J., Meijer, C.J.L.M., Pinedo, H.M.
Published in Vaccine (18.03.2005)
Published in Vaccine (18.03.2005)
Get full text
Journal Article
Conference Proceeding
Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma
Bakker, L J, Thielen, F W, Redekop, W K, Groot, Ca Uyl-de, Blommestein, H M
Published in BMC medical research methodology (29.05.2023)
Published in BMC medical research methodology (29.05.2023)
Get full text
Journal Article
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens
Oosten, L. E. M., Chamuleau, M. E. D., Thielen, F. W., de Wreede, L. C., Siemes, C., Doorduijn, J. K., Smeekes, O. S., Kersten, M. J., Hardi, L., Baars, J. W., Demandt, A. M. P., Stevens, W. B. C., Nijland, M., van Imhoff, G. W., Brouwer, R., Uyl-de Groot, C. A., Kluin, P. M., de Jong, D., Veelken, H.
Published in Annals of hematology (01.02.2018)
Published in Annals of hematology (01.02.2018)
Get full text
Journal Article
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population
Westgeest, H. M., Kuppen, M. C. P., van den Eertwegh, A. J. M., de Wit, R., Bergman, A. M., van Moorselaar, R. J. A., Coenen, J. L. L. M., van den Bergh, A. C. M., Somford, D. M., Mehra, N., van Oort, I. M., Aben, K. K. H., Gerritsen, W. R., Uyl-de Groot, C. A.
Published in Prostate cancer and prostatic diseases (01.09.2021)
Published in Prostate cancer and prostatic diseases (01.09.2021)
Get full text
Journal Article
Costs of Prostate Cancer, Metastatic to the Bone, in The Netherlands
Groot, M.T., Boeken Kruger, C.G.G., Pelger, R.C.M., Uyl-de Groot, C.A.
Published in European urology (01.03.2003)
Published in European urology (01.03.2003)
Get full text
Journal Article
Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study
Holtzer-Goor, K. M., Schaafsma, M. R., Joosten, P., Posthuma, E. F. M., Wittebol, S., Huijgens, P. C., Mattijssen, E. J. M., Vreugdenhil, G., Visser, H., Peters, W. G., Erjavec, Z., Wijermans, P. W., Daenen, S. M. G. J., van der Hem, K. G., van Oers, M. H. J., Uyl-de Groot, C. A.
Published in Quality of life research (01.12.2015)
Published in Quality of life research (01.12.2015)
Get full text
Journal Article
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
Franken, M.D, van Rooijen, E.M, May, A.M, Koffijberg, H, van Tinteren, H, Mol, L, ten Tije, A.J, Creemers, G.J, van der Velden, A.M.T, Tanis, B.C, Uyl-de Groot, C.A, Punt, C.J.A, Koopman, M, van Oijen, M.G.H
Published in European journal of cancer (1990) (01.04.2017)
Published in European journal of cancer (1990) (01.04.2017)
Get full text
Journal Article
Health related quality of life in patients with multiple myeloma undergoing a double transplantation
Uyl-de Groot, C. A., Buijt, I., Gloudemans, I. J. M., Ossenkoppele, G. J., van den Berg, H. P., Huijgens, P. C.
Published in European journal of haematology (01.02.2005)
Published in European journal of haematology (01.02.2005)
Get full text
Journal Article
A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study
van Agthoven, M., Segeren, C.M., Buijt, I., Uyl-de Groot, C.A., van der Holt, B., Lokhorst, H.M., Sonneveld, P.
Published in European journal of cancer (1990) (01.05.2004)
Published in European journal of cancer (1990) (01.05.2004)
Get full text
Journal Article
Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage
Prick, B. W., Duvekot, J. J., van der Moer, P. E., van Gemund, N., van der Salm, P. C. M., Jansen, A. J. G., van Rhenen, D. J., Mol, B. W., Uyl-de Groot, C. A.
Published in Vox sanguinis (01.11.2014)
Published in Vox sanguinis (01.11.2014)
Get full text
Journal Article